Gliagenesis Limited
- Company number
- 10902853
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 7 Aug 2017
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Oxandia Ltd (6 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BUTT, Arthur Morgan, Prof | Director | 23 Apr 2022 | |
| NORMANTON, John Raymond, Dr | Secretary | 7 Aug 2017 | |
| NORMANTON, John Raymond, Dr | Director | 7 Aug 2017 | |
| SOPWITH, Thomas Anthony Edward | Director | 6 Nov 2017 | 6 Apr 2022 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Prof Arthur Morgan Butt | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
9 May 2022 | |
| Oxandia Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
9 May 2022 | |
| Oxandia Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
7 Aug 2017 | 13 Nov 2017 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Aug 2025 | -£4,276 | - | 2 |
| 31 Aug 2024 | -£2,330 | - | 2 |
| 31 Aug 2023 | -£706 | £192 | 2 |
| 31 Aug 2022 | -£4,432 | £18 | 2 |
| 31 Aug 2021 | -£2,889 | £15 | 2 |
| 31 Aug 2020 | - | £9 | 2 |
| 31 Aug 2019 | - | £54 | 2 |
| 31 Aug 2018 | - | £351 | - |
Connections
Owned by
Gliagenesis Limited → Oxandia Ltd
Directors’ other companies
- NORMANTON, John Raymond, Dr - Director at Cholestenix Limited
- NORMANTON, John Raymond, Dr - Director at Lucilia Pharma Limited
- NORMANTON, John Raymond, Dr - Director at Estryx Pharma Limited